Kenya
· Delayed Price · Currency is KES NASE:BAT Statistics
Total Valuation
NASE:BAT has a market cap or net worth of KES 37.10 billion. The enterprise value is 35.30 billion.
| Market Cap | 37.10B |
| Enterprise Value | 35.30B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | May 26, 2025 |
Share Statistics
NASE:BAT has 100.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 100.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.77% |
| Float | 40.00M |
Valuation Ratios
The trailing PE ratio is 8.28.
| PE Ratio | 8.28 |
| Forward PE | n/a |
| PS Ratio | 1.44 |
| PB Ratio | 2.36 |
| P/TBV Ratio | 2.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 4.74 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 7.87 |
| EV / Sales | 1.37 |
| EV / EBITDA | 4.42 |
| EV / EBIT | 4.83 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.26
| Current Ratio | 2.26 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 8.82 |
Financial Efficiency
Return on equity (ROE) is 28.03% and return on invested capital (ROIC) is 28.56%.
| Return on Equity (ROE) | 28.03% |
| Return on Assets (ROA) | 19.16% |
| Return on Invested Capital (ROIC) | 28.56% |
| Return on Capital Employed (ROCE) | 41.48% |
| Revenue Per Employee | 14.29M |
| Profits Per Employee | 2.49M |
| Employee Count | 1,800 |
| Asset Turnover | 1.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.95% in the last 52 weeks. The beta is -0.02, so NASE:BAT's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -9.95% |
| 50-Day Moving Average | 370.19 |
| 200-Day Moving Average | 357.98 |
| Relative Strength Index (RSI) | 50.80 |
| Average Volume (20 Days) | 10,685 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NASE:BAT had revenue of KES 25.72 billion and earned 4.48 billion in profits. Earnings per share was 44.83.
| Revenue | 25.72B |
| Gross Profit | 7.31B |
| Operating Income | 7.31B |
| Pretax Income | 6.48B |
| Net Income | 4.48B |
| EBITDA | 7.99B |
| EBIT | 7.31B |
| Earnings Per Share (EPS) | 44.83 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 15.73B |
| Book Value Per Share | 157.33 |
| Working Capital | 7.57B |
Cash Flow
| Operating Cash Flow | 7.83B |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 28.44%, with operating and profit margins of 28.44% and 17.43%.
| Gross Margin | 28.44% |
| Operating Margin | 28.44% |
| Pretax Margin | 25.21% |
| Profit Margin | 17.43% |
| EBITDA Margin | 31.06% |
| EBIT Margin | 28.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 13.48%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 13.48% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 13.48% |
| Earnings Yield | 12.08% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 13, 2000. It was a forward split with a ratio of 1.33333.
| Last Split Date | Mar 13, 2000 |
| Split Type | Forward |
| Split Ratio | 1.33333 |
Scores
NASE:BAT has an Altman Z-Score of 6.06.
| Altman Z-Score | 6.06 |
| Piotroski F-Score | n/a |